The Campbell Family Institute for Cancer Research

The Campbell Family Institute for Cancer Research

Amount
$100,000.00
Date
October 2017

Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets

Anchutz Medical Campus

Anchutz Medical Campus

Amount
$50,000.00
Date
October 2017

Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.

Ann & Robert H. Lurie Children’s Hospital

Ann & Robert H. Lurie Children’s Hospital

Amount
$100,000.00
Date
October 2017

Determine the efficacy of BMP and MEK inhibitors with RT to treat ACVR1 mutant DIPG

Children's Cancer Institute (AU)

Children's Cancer Institute (AU)

Amount
$185,706.00
Date
October 2017

Developing novel combination therapeutic approaches for DIPG targeting Polo-like Kinase 1

Children's National Medical Center

Children's National Medical Center

Amount
$200,000.00
Date
October 2017

Validation of TAK228 as an effective drug for treating children with DIPG

Cincinnati Children's Hospital Medical Center

Cincinnati Children's Hospital Medical Center

Amount
$2,759,496.00
Date
October 2017

CONNECT Collaborative

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Amount
$100,000.00
Date
October 2017

Defining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-sequencing analyses

Gustave Roussy

Gustave Roussy

Amount
$101,868.00
Date
October 2017

Elucidating the underlying mechanisms of radio resistance at diagnosis and relapse in DIPG